Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 2/10

vs
industry
vs
history
Cash-to-Debt 0.12
CRGS's Cash-to-Debt is ranked lower than
93% of the 2056 Companies
in the Global Health Information Services industry.

( Industry Median: 5.32 vs. CRGS: 0.12 )
Ranked among companies with meaningful Cash-to-Debt only.
CRGS' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.05  Med: 9.69 Max: No Debt
Current: 0.12
0.05
No Debt
Equity-to-Asset -1.30
CRGS's Equity-to-Asset is ranked lower than
98% of the 1962 Companies
in the Global Health Information Services industry.

( Industry Median: 0.59 vs. CRGS: -1.30 )
Ranked among companies with meaningful Equity-to-Asset only.
CRGS' s Equity-to-Asset Range Over the Past 10 Years
Min: -2.82  Med: 0.38 Max: 0.97
Current: -1.3
-2.82
0.97
Piotroski F-Score: 2
Altman Z-Score: -133.93
Beneish M-Score: -10.02
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating Margin % -15631.03
CRGS's Operating Margin % is ranked lower than
100% of the 1998 Companies
in the Global Health Information Services industry.

( Industry Median: 4.54 vs. CRGS: -15631.03 )
Ranked among companies with meaningful Operating Margin % only.
CRGS' s Operating Margin % Range Over the Past 10 Years
Min: -15631.03  Med: -5272 Max: -1892.57
Current: -15631.03
-15631.03
-1892.57
Net Margin % -17944.83
CRGS's Net Margin % is ranked lower than
100% of the 1998 Companies
in the Global Health Information Services industry.

( Industry Median: 3.39 vs. CRGS: -17944.83 )
Ranked among companies with meaningful Net Margin % only.
CRGS' s Net Margin % Range Over the Past 10 Years
Min: -17944.83  Med: -5206 Max: -1390.91
Current: -17944.83
-17944.83
-1390.91
ROE % -2824.87
CRGS's ROE % is ranked lower than
99% of the 1945 Companies
in the Global Health Information Services industry.

( Industry Median: 6.04 vs. CRGS: -2824.87 )
Ranked among companies with meaningful ROE % only.
CRGS' s ROE % Range Over the Past 10 Years
Min: -2824.87  Med: -199.5 Max: -81.31
Current: -2824.87
-2824.87
-81.31
ROA % -390.05
CRGS's ROA % is ranked lower than
98% of the 2074 Companies
in the Global Health Information Services industry.

( Industry Median: 3.03 vs. CRGS: -390.05 )
Ranked among companies with meaningful ROA % only.
CRGS' s ROA % Range Over the Past 10 Years
Min: -609.31  Med: -149.92 Max: -66.88
Current: -390.05
-609.31
-66.88
ROC (Joel Greenblatt) % -3462.12
CRGS's ROC (Joel Greenblatt) % is ranked lower than
94% of the 2045 Companies
in the Global Health Information Services industry.

( Industry Median: 21.71 vs. CRGS: -3462.12 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
CRGS' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -3462.12  Med: -1288.18 Max: -664.63
Current: -3462.12
-3462.12
-664.63
3-Year EBITDA Growth Rate 12.50
CRGS's 3-Year EBITDA Growth Rate is ranked higher than
59% of the 1456 Companies
in the Global Health Information Services industry.

( Industry Median: 7.70 vs. CRGS: 12.50 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
CRGS' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -32.7  Med: -8.15 Max: 29
Current: 12.5
-32.7
29
3-Year EPS without NRI Growth Rate 16.30
CRGS's 3-Year EPS without NRI Growth Rate is ranked higher than
62% of the 1364 Companies
in the Global Health Information Services industry.

( Industry Median: 7.70 vs. CRGS: 16.30 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
CRGS' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -33.3  Med: -6.85 Max: 54.2
Current: 16.3
-33.3
54.2
GuruFocus has detected 2 Warning Signs with CurAegis Technologies Inc CRGS.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» CRGS's 30-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

CRGS Guru Trades in

CRGS Guru Trades in

Q2 2016

CRGS Guru Trades in Q2 2016

John Buckingham 12,400 sh (New)
» More
Q3 2016

CRGS Guru Trades in Q3 2016

John Buckingham Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with CRGS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

CurAegis Technologies Inc does not have enough historical financial data to display Peter Lynch Chart.

Business Description

Industry: Application Software » Health Information Services    NAICS: 444110    SIC: 8082
Compare:OTCPK:EWLL, OTCPK:TLLT, TSXV:ADK, OTCPK:PAXH, ROCO:8409, XCNQ:HS, ASX:NHL, XPAR:MED, XPAR:SDT, OSL:INDUCT-ME, OTCPK:CLOK, ASX:ICS, ASX:ALC, OTCPK:AGTK, XPAR:MLSBT, TSXV:HSI, ASX:1ST, TSXV:NGH.H, ASX:GLH, TSXV:EYC » details
Headquarter Location:USA
CurAegis Technologies Inc is engaged in developing and marketing of advanced technologies in the areas of power, safety, wellness and hydraulic power.

CurAegis Technologies Inc is an US-based company which develops and markets advanced technologies in the areas of power, safety, wellness and hydraulic power. It is focused on the commercialization of a wellness and safety system and a uniquely designed hydraulic pump that will be smaller, lighter and more efficient than current technology. The company has two business divisions CURA and Aegis. The CURA division is engaged in the fatigue management business and the Aegis division is engaged in the power and hydraulic business. The CURA System reduces fatigue risk in the workplace to improve alertness. Aegis hydraulic pump technology has been designed to bring a unique concept in hydraulic pumps and motors. Most of the company's revenue comes from CURA division.

Ratios

vs
industry
vs
history
EV-to-Revenue 599.27
CRGS's EV-to-Revenue is ranked lower than
99% of the 1973 Companies
in the Global Health Information Services industry.

( Industry Median: 2.44 vs. CRGS: 599.27 )
Ranked among companies with meaningful EV-to-Revenue only.
CRGS' s EV-to-Revenue Range Over the Past 10 Years
Min: 64.7  Med: 343.5 Max: 4293.4
Current: 599.27
64.7
4293.4
Current Ratio 0.46
CRGS's Current Ratio is ranked lower than
93% of the 1975 Companies
in the Global Health Information Services industry.

( Industry Median: 1.93 vs. CRGS: 0.46 )
Ranked among companies with meaningful Current Ratio only.
CRGS' s Current Ratio Range Over the Past 10 Years
Min: 0.01  Med: 0.6 Max: 32.8
Current: 0.46
0.01
32.8
Quick Ratio 0.34
CRGS's Quick Ratio is ranked lower than
94% of the 1975 Companies
in the Global Health Information Services industry.

( Industry Median: 1.78 vs. CRGS: 0.34 )
Ranked among companies with meaningful Quick Ratio only.
CRGS' s Quick Ratio Range Over the Past 10 Years
Min: 0.01  Med: 0.56 Max: 32.8
Current: 0.34
0.01
32.8
Days Inventory 70.50
CRGS's Days Inventory is ranked lower than
79% of the 1173 Companies
in the Global Health Information Services industry.

( Industry Median: 17.76 vs. CRGS: 70.50 )
Ranked among companies with meaningful Days Inventory only.
CRGS' s Days Inventory Range Over the Past 10 Years
Min: 34.49  Med: 149.05 Max: 263.61
Current: 70.5
34.49
263.61
Days Sales Outstanding 12.59
CRGS's Days Sales Outstanding is ranked higher than
95% of the 1631 Companies
in the Global Health Information Services industry.

( Industry Median: 67.98 vs. CRGS: 12.59 )
Ranked among companies with meaningful Days Sales Outstanding only.
CRGS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 12.59  Med: 140.38 Max: 140.38
Current: 12.59
12.59
140.38
Days Payable 707.50
CRGS's Days Payable is ranked higher than
99% of the 1422 Companies
in the Global Health Information Services industry.

( Industry Median: 45.15 vs. CRGS: 707.50 )
Ranked among companies with meaningful Days Payable only.
CRGS' s Days Payable Range Over the Past 10 Years
Min: 265.82  Med: 793.88 Max: 1953.82
Current: 707.5
265.82
1953.82

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -1.00
CRGS's 3-Year Average Share Buyback Ratio is ranked higher than
66% of the 1353 Companies
in the Global Health Information Services industry.

( Industry Median: -3.20 vs. CRGS: -1.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CRGS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -13  Med: -4 Max: 0
Current: -1
-13
0

Valuation & Return

vs
industry
vs
history
Earnings Yield (Greenblatt) % -26.30
CRGS's Earnings Yield (Greenblatt) % is ranked lower than
94% of the 2078 Companies
in the Global Health Information Services industry.

( Industry Median: 2.18 vs. CRGS: -26.30 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CRGS' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -69.7  Med: -12.8 Max: -3.2
Current: -26.3
-69.7
-3.2

More Statistics

Revenue (TTM) (Mil) $0.03
EPS (TTM) $ -0.10
Beta-1.67
Short Percentage of Float0.00%
52-Week Range $0.25 - 1.64
Shares Outstanding (Mil)48.80

Piotroski F-Score Details

Piotroski F-Score: 22
Positive ROAN
Positive CFROAN
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyN
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}